TRAF4 and breast cancer: To assess the clinical relevance of TRAF4 nuclear translocation, we performed immunohistochemical staining (IHC) analyses on tissue microarrays derived from human breast cancer (Figure1A–C), colon cancer (Figure 1D–F), and glioma (Figure 1G–I).